Tag Archives: ENBL

Top High Tech Stocks To Buy Right Now

KPMG LLP is conducting an internal review into its audits of embattled Middle East buyout firm Abraaj Group following the alleged misuse of money, according to people with knowledge of the matter.

The accounting firm’s U.K. branch is looking into its examination of Abraaj and its related companies for any potential irregularities in the valuation of assets by KPMG’s Middle East division, the people said, asking not to be identified because the information is private. KPMG is also studying its examination of Abraaj’s $1 billion health-care fund, which was completed in February, they said. The reviews are ongoing and the outcome isn’t clear, the people said.

While KPMG said it couldn’t comment on the specifics of the matter because of client confidentiality, a spokesman added that KPMG has taken steps to ensure that investors in the fund have had the opportunity to receive a copy of the KPMG U.A.E. report from February to “see for themselves what it says.”

Top High Tech Stocks To Buy Right Now: Washington Trust Bancorp, Inc.(WASH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Washington Trust Bancorp (NASDAQ:WASH) hit a new 52-week high and low during trading on Friday . The company traded as low as $60.60 and last traded at $60.15, with a volume of 256 shares traded. The stock had previously closed at $60.15.

  • [By Shane Hupp]

    BidaskClub downgraded shares of Washington Trust Bancorp (NASDAQ:WASH) from a sell rating to a strong sell rating in a report published on Tuesday.

Top High Tech Stocks To Buy Right Now: Nuveen AMT-Free Municipal Income Fund(NEA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Wells Fargo & Company MN raised its holdings in Nuveen AMT-Free Municipal (NYSE:NEA) by 8.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 4,674,452 shares of the company’s stock after buying an additional 372,370 shares during the period. Wells Fargo & Company MN’s holdings in Nuveen AMT-Free Municipal were worth $60,768,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    BB&T Securities LLC cut its holdings in Nuveen Amt-Free Quality Municpl Incm Fnd (NYSE:NEA) by 3.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 260,949 shares of the company’s stock after selling 10,037 shares during the quarter. BB&T Securities LLC owned about 0.10% of Nuveen Amt-Free Quality Municpl Incm Fnd worth $3,392,000 at the end of the most recent quarter.

Top High Tech Stocks To Buy Right Now: Westar Energy, Inc.(WR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Public Service Enterprise Group (NYSE: PEG) and Westar Energy (NYSE:WR) are both utilities companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

  • [By Lisa Levin]

    Friday afternoon, the utilities shares surged 0.43 percent. Meanwhile, top gainers in the sector included Spark Energy, Inc. (NASDAQ: SPKE), up 4 percent, and Westar Energy, Inc. (NYSE: WR) up 3 percent.

  • [By Joseph Griffin]

    Westar Energy Inc (NYSE:WR)’s share price reached a new 52-week high and low on Thursday . The company traded as low as $57.44 and last traded at $57.25, with a volume of 29399 shares. The stock had previously closed at $57.04.

Top High Tech Stocks To Buy Right Now: Enable Midstream Partners, LP(ENBL)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Enable Midstream Partners LP  (NYSE:ENBL)Q4 2018 Earnings Conference CallFeb. 19, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Enable Midstream Partners (ENBL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Enable Midstream Partners (NYSE:ENBL) had its price target lifted by research analysts at Wells Fargo & Co from $16.00 to $18.00 in a report released on Friday. The firm currently has a “market perform” rating on the pipeline company’s stock. Wells Fargo & Co’s price target indicates a potential upside of 1.24% from the company’s current price.

  • [By Lee Jackson]

    Enable Midstream Partners LP (NYSE: ENBL) is raised to equal weight from underweight at Barclays. The 52-week trading range for the stock has been $12.89 to $17.67. The consensus price target is set at $17.18. The price of shares at the market’s close on Monday was $17.02.

Top High Tech Stocks To Buy Right Now: Brunswick Corporation(BC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Brunswick Co. (NYSE:BC) insider William Metzger sold 13,530 shares of the firm’s stock in a transaction that occurred on Tuesday, June 5th. The stock was sold at an average price of $67.42, for a total transaction of $912,192.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By Rich Duprey]

    Pontoon boats are a versatile vessel as they can be used for fishing, sports, cruising, and day trips. That latter part is key because rival boatmaker Brunswick (NYSE:BC) — which Polaris used to have a business relationship with when it was in the marine market — says that overnight trips with boats are fading. Industry site Boat Industry quotes Brunswick’s freshwater boat group President Jeff Kinsey as saying, “There’s been a clear shift toward day boating, and that speaks directly to the pontoon with its seating capacity, its open space, its amenities and its comfort.”

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY WARNING: “$1.15 Billion in Sales Expected for Brunswick Co. (BC) This Quarter” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/3380347/1-15-billion-in-sales-expected-for-brunswick-co-bc-this-quarter.html.

  • [By Shane Hupp]

    Shares of Brunswick Co. (NYSE:BC) have been given a consensus recommendation of “Buy” by the eighteen brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $71.33.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brunswick (BC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Performing Stocks To Watch For 2019

 

Ten years after the financial crash that caused the Great Recession, the U.S. economy is performing remarkably well. And while President Donald Trump is quick to take credit, the real hero is the Federal Reserve.

Under three different leaders, the nation’s central bank took extraordinary steps to prevent another depression and nurture back to health a once-fragile economy that is now the second longest expansion in U.S. history. Yet that enviable track record hasn’t deterred Trump from assailing the Fed for raising interest rates to keep inflation in check.

The Fed announced Wednesday that, as expected, it was nudging up rates again from historically low levels, and Trump used his opening statement at a subsequent news conference in New York to harangue the Fed for threatening to slow the economy.

Top 5 Performing Stocks To Watch For 2019: Aquinox Pharmaceuticals, Inc.(AQXP)

Advisors’ Opinion:

  • [By Paul Ausick]

    Aquinox Pharmaceuticals Inc. (NASDAQ: AQXP) dropped about nearly 85% Wednesday to post a new 52-week low of $2.25. Shares closed at $15.31 on Tuesday and the stock’s 52-week high is $16.90. Volume totaled 13.5 million shares compared to a daily average of less than 200,000. The company’s bladder pain drug failed a trial and the company is stopping development.

  • [By Chris Lange]

    Aquinox Pharmaceuticals Inc. (NASDAQ: AQXP) saw its shares crash on Wednesday after the firm gave a disappointing update for a late-stage trial. Unfortunately, the firm’s Phase 3 LEADERSHIP 301 clinical trial evaluating rosiptor (AQX-1125) for the treatment of interstitial cystitis/bladder pain syndrome failed to meet its primary endpoint.

  • [By Steve Symington]

    Still, some individual companies fared worse than most. Read on to learn why Sonic Corporation (NASDAQ:SONC), National Beverage (NASDAQ:FIZZ), and Aquinox Pharmaceuticals (NASDAQ:AQXP) plunged today.

Top 5 Performing Stocks To Watch For 2019: Douglas Dynamics Inc.(PLOW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Douglas Dynamics (PLOW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Douglas Dynamics (NYSE: PLOW) and Astec Industries (NASDAQ:ASTE) are both small-cap auto/tires/trucks companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

  • [By Ethan Ryder]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Douglas Dynamics alerts:

    Douglas Dynamics (PLOW) Expected to Announce Quarterly Sales of $148.45 Million (americanbankingnews.com) Critical Contrast: Astec Industries (ASTE) and Douglas Dynamics (PLOW) (americanbankingnews.com) $0.78 Earnings Per Share Expected for Douglas Dynamics (PLOW) This Quarter (americanbankingnews.com) Astec Industries (ASTE) & Douglas Dynamics (PLOW) Critical Comparison (americanbankingnews.com)

    A number of research firms recently commented on PLOW. Craig Hallum set a $50.00 price objective on Douglas Dynamics and gave the stock a “buy” rating in a report on Wednesday, February 28th. Zacks Investment Research upgraded Douglas Dynamics from a “hold” rating to a “buy” rating and set a $50.00 price objective on the stock in a report on Friday, May 11th. ValuEngine upgraded Douglas Dynamics from a “hold” rating to a “buy” rating in a report on Wednesday, March 7th. Finally, Robert W. Baird restated a “hold” rating and issued a $44.00 price objective on shares of Douglas Dynamics in a report on Thursday, March 1st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $48.00.

  • [By Max Byerly]

    News stories about Douglas Dynamics (NYSE:PLOW) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Douglas Dynamics earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave media headlines about the auto parts company an impact score of 47.2246052290592 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Max Byerly]

    Douglas Dynamics Inc (NYSE:PLOW) Chairman James L. Janik sold 25,000 shares of Douglas Dynamics stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $44.89, for a total transaction of $1,122,250.00. Following the sale, the chairman now directly owns 239,030 shares in the company, valued at approximately $10,730,056.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Top 5 Performing Stocks To Watch For 2019: SI Financial Group Inc.(SIFI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Teton Advisors Inc. acquired a new position in shares of SI Financial Group, Inc. (NASDAQ:SIFI) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 10,342 shares of the savings and loans company’s stock, valued at approximately $153,000. Teton Advisors Inc. owned about 0.08% of SI Financial Group as of its most recent SEC filing.

  • [By Logan Wallace]

    Renaissance Technologies LLC lifted its stake in shares of SI Financial Group, Inc. (NASDAQ:SIFI) by 17.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 458,700 shares of the savings and loans company’s stock after acquiring an additional 69,800 shares during the period. Renaissance Technologies LLC’s holdings in SI Financial Group were worth $6,766,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    News coverage about SI Financial Group (NASDAQ:SIFI) has been trending somewhat negative recently, according to Accern. The research firm rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. SI Financial Group earned a media sentiment score of 0.00 on Accern’s scale. Accern also gave news articles about the savings and loans company an impact score of 44.7479870139738 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Logan Wallace]

    News articles about SI Financial Group (NASDAQ:SIFI) have been trending somewhat positive recently, Accern reports. Accern identifies positive and negative press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. SI Financial Group earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned news stories about the savings and loans company an impact score of 47.0536892575283 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By ]

    There are 30 banks that qualify as systemically important financial institutions (SIFI), according to the Financial Stability Board’s most recent list. Half have seen their stocks fall at least 20 percent from the most recent peaks, according to a Bloomberg analysis. Notably, no large U.S.-based banks make the list.

Top 5 Performing Stocks To Watch For 2019: RadNet, Inc.(RDNT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Biocept (NASDAQ: RDNT) and RadNet (NASDAQ:RDNT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability.

  • [By Ethan Ryder]

    RadNet Inc. (NASDAQ:RDNT) reached a new 52-week high during trading on Tuesday . The stock traded as high as $15.65 and last traded at $15.55, with a volume of 15009 shares changing hands. The stock had previously closed at $15.15.

  • [By Ethan Ryder]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s scoring:

    Get RadNet alerts:

    Edited Transcript of RDNT earnings conference call or presentation 9-Aug-18 2:30pm GMT (finance.yahoo.com) Stocks Favored By Analysts: RadNet, Inc. (NASDAQ:RDNT) & RCI Hospitality Holdings, Inc. (NASDAQ:RICK) (baycityobserver.com) RadNet, Inc. (RDNT) stock closes -0.37% above from its SMA-50 (nasdaqplace.com) $241.29 Million in Sales Expected for RadNet Inc. (RDNT) This Quarter (americanbankingnews.com) Zacks: Analysts Expect RadNet Inc. (RDNT) to Announce $0.15 EPS (americanbankingnews.com)

    Shares of RDNT traded up $0.20 during trading hours on Friday, hitting $14.10. The stock had a trading volume of 128,336 shares, compared to its average volume of 171,176. The company has a debt-to-equity ratio of 4.49, a current ratio of 1.06 and a quick ratio of 1.06. The company has a market cap of $678.40 million, a PE ratio of 48.62, a P/E/G ratio of 5.02 and a beta of 0.32. RadNet has a 1-year low of $9.50 and a 1-year high of $15.50.

Top 5 Performing Stocks To Watch For 2019: Enable Midstream Partners, LP(ENBL)

Advisors’ Opinion:

  • [By Lee Jackson]

    Enable Midstream Partners LP (NYSE: ENBL) is raised to equal weight from underweight at Barclays. The 52-week trading range for the stock has been $12.89 to $17.67. The consensus price target is set at $17.18. The price of shares at the market’s close on Monday was $17.02.

  • [By Joseph Griffin]

    Enable Midstream Partners (NYSE:ENBL) had its price target lifted by research analysts at Wells Fargo & Co from $16.00 to $18.00 in a report released on Friday. The firm currently has a “market perform” rating on the pipeline company’s stock. Wells Fargo & Co’s price target indicates a potential upside of 1.24% from the company’s current price.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Enable Midstream Partners (ENBL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks For 2019

&l;p&g;&l;img class=&q;size-full wp-image-843&q; src=&q;http://blogs-images.forbes.com/andrewrossow/files/2018/05/IMG_4209.jpg?width=960&q; alt=&q;&q; data-height=&q;623&q; data-width=&q;980&q;&g; &s;Larry King – CNN Legend &a;amp; GEAR Advisory Board member&s;

&l;span style=&q;font-weight: 400&q;&g;It is hard to imagine a world without air conditioners, vehicles or the internet. Technology has had a great impact on our world and the people who inhibit the earth today. People are living longer because technology has allowed medical research to advance. Those people are able to live anywhere in the world, in any type of housing imaginable and are able to do things that even 30 years ago seemed impossible. And technology advancements do not appear to be stopping anytime in the near future. &a;nbsp;Even though technology has advanced our capabilities and allowed us to live fuller lives, it does come with a price. &l;/span&g;

&l;span style=&q;font-weight: 400&q;&g;One of the greatest technological advances known to man was the invention of electricity. Now, hundreds of years later, almost everything we do requires electricity. And as we do more and more, we need more and more of it. Unfortunately, producing that electricity which helps us live better lives can be detrimental to the environment. Most of our electricity is generated from non-renewable sources that pollute our air and water.&l;/span&g;

Best Medical Stocks For 2019: IF Bancorp, Inc.(IROQ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Press coverage about IF Bancorp (NASDAQ:IROQ) has trended somewhat negative on Tuesday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. IF Bancorp earned a media sentiment score of -0.01 on Accern’s scale. Accern also assigned news headlines about the savings and loans company an impact score of 46.0647914274093 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Max Byerly]

    News stories about IF Bancorp (NASDAQ:IROQ) have been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. IF Bancorp earned a news sentiment score of 0.16 on Accern’s scale. Accern also gave news coverage about the savings and loans company an impact score of 47.5310825195986 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Stephan Byrd]

    Media headlines about IF Bancorp (NASDAQ:IROQ) have trended somewhat negative this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. IF Bancorp earned a daily sentiment score of -0.01 on Accern’s scale. Accern also gave news articles about the savings and loans company an impact score of 44.9246663755848 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Best Medical Stocks For 2019: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By Stephen Mack]

    Our investing experts have made some tremendous picks over the last several years, outperforming the S&P 500 by 100%, 200%, or even as much as 700% in the case of Money Morning Executive Editor Bill Patalon’s 2012 pick of Galapagos NV (Nasdaq: GLPG).

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

  • [By Keith Speights]

    As icing on the cake, Gilead Sciences and partner Galapagos NV (NASDAQ:GLPG) will soon report results from a phase 3 clinical study of JAK1 inhibitor filgotinib in treating rheumatoid arthritis. If those results are positive, the biotech could be looking at peak annual sales of between $2 billion and $3 billion in the indication.

Best Medical Stocks For 2019: Luxoft Holding, Inc.(LXFT)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Luxoft Holding (NYSE:LXFT) Q4 2018 Earnings Conference CallMay. 24, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Luxoft (LXFT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Luxoft Holding, Inc. (NYSE: LXFT) was down, falling around 26 percent to $32.15. Luxoft posted in-line Q4 earnings, but issued weak forecast for the current quarter.

Best Medical Stocks For 2019: Almost Family Inc(AFAM)

Advisors’ Opinion:

  • [By Max Byerly]

    Schwab Charles Investment Management Inc. boosted its position in shares of Almost Family Inc (NASDAQ:AFAM) by 12.6% during the first quarter, HoldingsChannel reports. The firm owned 62,175 shares of the company’s stock after buying an additional 6,953 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in Almost Family were worth $3,482,000 at the end of the most recent reporting period.

Best Medical Stocks For 2019: Enable Midstream Partners, LP(ENBL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Enable Midstream Partners (ENBL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enable Midstream Partners LP (NYSE:ENBL) has been given a consensus recommendation of “Hold” by the fourteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $17.75.

  • [By Stephan Byrd]

    Enable Midstream Partners (NYSE: ENBL) and EnLink Midstream Partners (NYSE:ENLK) are both mid-cap oils/energy companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

  • [By Lee Jackson]

    Enable Midstream Partners LP (NYSE: ENBL) is raised to equal weight from underweight at Barclays. The 52-week trading range for the stock has been $12.89 to $17.67. The consensus price target is set at $17.18. The price of shares at the market’s close on Monday was $17.02.